bioSyntagma is a precision medicine company dedicated to transforming how cancer is treated by providing deep data on the uniqueness of each person’s cancer. The company’s Molecular Fingerprint™ (mPrint™) platform creates a comprehensive, multi-omic and spatial profile of tissue to get a complete and informed understanding of the patient’s cancer so they can be matched with relevant therapies and recommended course of actions that prevent acquired drug resistance. bioSyntagma’s mPrint™ platform serves the needs of clinicians, academic researchers, and drug developers to advance the implementation of precision medicine for cancer treatment.
Looking for a particular bioSyntagma employee's phone or email?
The bioSyntagma annual revenue was $8 million in 2026.
1 people are employed at bioSyntagma.
bioSyntagma is based in Phoenix, Arizona.
The NAICS codes for bioSyntagma are [54171, 54, 5417, 541, 541713].
The SIC codes for bioSyntagma are [873, 87].